What’s Intriguing And Concerning About Early Results For Keytruda In Breast Cancer

as seen in Forbes

What’s concerning about the preliminary findings is that the median time to response was 18 weeks. For patients to wait four months or longer to see if there’s a benefit seems like a lot; these are women without much time to spare.